| abstract |
The present disclosure provides methods of treating subjects with elevated serum glucose levels and/or hyperglycemia, methods of identifying subjects at increased risk of developing elevated serum glucose levels and/or hyperglycemia, and assays Methods for Human Solute Carrier Family 39 Member 5 Variant Nucleic Acid Molecules and Methods for Variant Polypeptides. |